Back to search
Cholangiocarcinoma, Perihilar
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cholangiocarcinoma, Perihilar trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cholangiocarcinoma, Perihilar trials you may qualify forLITALHICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable perihilar cholang…
This is an open-label,single center,non-randomized,single arm exploratory study. The objective of this study is to evaluate the efficacy and safety of PD-1 anti…
The present clinical trial is a prospective, investigator-initiated, single-arm, open-label, multicenter phase II trial. Patients with unresectable perihilar an…
Surgery for hilar cholangiocarcinoma (phCCA) remains a significant challenge. The minority of patients who are eligible for resection are exposed to high proced…
The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cance…
The objective of this study is to evaluate the efficacy of stereotactic body radiation therapy (SBRT) as additional treatment after standard chemotherapy regard…
This study is a prospective, single-arm, phase II clinical trial designed to evaluate the safety and efficacy of PD-L1 monoclonal antibody combined with chemora…
Purpose of the Study: Bile duct cancers are rare and aggressive. About 250 new cases are diagnosed each year in Denmark. These cancers are difficult to detect…
A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in partici…